Floatz logo

Therapeutic Asset Ratings

615 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Fluzoparib
Neoadjuvant Therapy
Fudan UniversityP3B (59)
Osimertinib
Metastatic Malignant Neoplasm In The Brain
Fudan UniversityP3B (59)
Rivoceranib
Neoadjuvant Therapy
Fudan UniversityP3B (59)
Shr-A1811
Triple-Negative Breast Carcinoma
Fudan UniversityP3B (59)
Sorafenib
Breast Cancer
Fudan UniversityP3B (59)
CIS-DIAMMINEDICHLOROPLATINUM II
Rhabdomyosarcoma
Fudan UniversityP2B (59)
1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-
Breast Cancer
Fudan UniversityP4B (58)
FALLYPRIDE
Breast Cancer
Fudan UniversityP4B (58)
Huaier Granule
Breast Cancer
Fudan UniversityP4B (58)
Huaier Granule
Colorectal Cancer
Fudan UniversityP4B (58)
METHOTREXATE
Her2-Receptor Negative Breast Cancer
Fudan UniversityP4B (58)
CIS-DIAMMINEDICHLOROPLATINUM II
Metastatic Malignant Neoplasm In The Brain
Fudan UniversityP3B (58)
VEMURAFENIB
Metastatic Malignant Neoplasm In The Colon
Fudan UniversityP3B (58)
CIS-DIAMMINEDICHLOROPLATINUM II
Testicular Cancer
Fudan UniversityP2B (58)
Fruquintinib
Colorectal Carcinoma
Fudan UniversityP2B (58)
LENVATINIB
Pancreatic Ductal Adenocarcinoma
Fudan UniversityP2B (58)
Mitoxantrone
Hepatocellular Carcinoma
Fudan UniversityP2B (58)
Pyrotinib
Advanced Colorectal Carcinoma
Fudan UniversityP2B (58)
rc48-adc
Advanced Colorectal Carcinoma
Fudan UniversityP2B (58)
Ddctx
Triple-Negative Breast Carcinoma
Fudan UniversityP3B (57)
Ddepirubicin
Triple-Negative Breast Carcinoma
Fudan UniversityP3B (57)
Docetaxel
Breast Tumor Luminal A Or B
Fudan UniversityP3B (57)
Everolimus
Mutation
Fudan UniversityP3B (57)
Lornoxicam
Triple-Negative Breast Carcinoma
Fudan UniversityP3B (57)
Neratinib
HER2 Positive Breast Carcinoma
Fudan UniversityP3B (57)
Showing 126 to 150 of 615 assets
PreviousPage 6 of 25Next